Clinical Research Facility at Royal Brompton Hospital awarded funding

The Cardiorespiratory Clinical Research Facility at Royal Brompton and Harefield hospitals has been awarded funding as part of a successful bid by Guy’s and St Thomas’ NHS Foundation Trust (GSTT).

The £11.8m funding from the National Institute for Health Research will be used to conduct ground-breaking clinical research studies across GSTT including facilities at Royal Brompton and Harefield hospitals, St Thomas’ Hospital, Evelina London Children’s Hospital and Guy’s Hospital.

The Cardiorespiratory Clinical Research Facility at Royal Brompton Hospital was previously funded by the NIHR from 2010 through to 2017 before becoming an independent research facility. The facility will now benefit from an uplift in funding, making it possible it to expand on the heart and lung research projects which can take place there.

Based on the first floor of Fulham wing at Royal Brompton Hospital, the facility boasts state of the art facilities and is in close proximity to the clinical services provided by the hospital, allowing convenient patient access to new treatment opportunities.

The facility currently delivers early phase (phase 1b,2a & 2b), later phase (phase 3 & 4) as well as observational studies and projects focused on health promotion and quality of life improvement across a spectrum of cardiac and respiratory diseases.

Dr Philip Molyneaux, director of the facility said: “This NIHR award is the culmination of a lot of hard work from the whole research team. It is fantastic news for our patients and researchers. It will allow us to continue to provide world class facilities and the expertise to support the testing and development of new therapies to help patients with heart and lung disease.”

Professor Martin Cowie, director of cardiovascular research, said: “This is excellent news for patients taking part in ground-breaking studies in heart and lung disease – we will be able to improve facilities and help establish new approaches to diagnosis and treatment.”

You can read more about the funding here.